FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the treatment of myeloproliferative neoplasms. The following is disclosed: the use of a compound of formula II or a pharmaceutically acceptable salt thereof in the preparation of a medicinal product for the treatment of a myeloproliferative neoplasm, a solid pharmaceutical composition for the treatment of a myeloproliferative neoplasm containing a compound of formula II or a pharmaceutically acceptable salt thereof, and a diluent, a binder, a wetting agent and a disintegrant, and the use of such solid pharmaceutical composition in the preparation of a medicinal product for the treatment of myeloproliferative neoplasm.
EFFECT: use of the invention makes it possible to effectively treat myeloproliferative neoplasms.
15 cl, 9 tbl, 6 ex
| Title |
Year |
Author |
Number |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING TLR7 AGONIST |
2020 |
- Jing, Jianghui
- Dong, Lihui
- Xu, Yi
- Li, Xinlu
- Lu, Xifeng
- Wang, Shang
- Zang, Haishan
- Li, Min
- Chen, Zhilin
- Zhao, Xiandong
- Sun, Peng
|
RU2822480C2 |
| PYRROLOPYRIMIDINE COMPOUND |
2015 |
- Zhu Li
- Xiao Dengming
- Hu Yuandong
- Dai Liguang
- Duan Xiaowei
- Sun Yinghui
- Peng Yong
- Kong Fansheng
- Luo Hong
- Han Yongxin
- Yang Ling
- Wang Shanchun
|
RU2701206C2 |
| SOLID PHARMACEUTICAL PREPARATION, METHOD OF ITS PREPARATION AND USE |
2021 |
- Tszyan, Taotao
- Van, Tszibyao
- Yan, Khan
- Li, Li
- Dan, Chzhaolin
- Chzhu, Kei
- Tszen, Chzhenya
- Su, Bo
- Chen, Si
|
RU2809722C1 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yungo
- Van, Gaosen
- Gao, Khuejshen
|
RU2772875C1 |
| COMPOUNDING, WHICH INHIBITES ACTIVITY OF BTK AND/OR JAK3 KINASES |
2014 |
- Liu Jinming
- Cha Mi Young
- Li Gong
- Li Zhanmei
- Qiu Hongjuan
- Kim Maengsup
|
RU2650512C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
|
RU2780377C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND, CONTAINING A GLUCOKINASE ACTIVATOR AND AN ALPHA-GLUCOSIDASE INHIBITOR, METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2775603C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2781638C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND AN SGLT-2 INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2770043C1 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A DPP-IV INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF |
2019 |
- Chen, Li
- Li, Yongguo
- Wang, Gaosen
- Gao, Huisheng
|
RU2770775C1 |
